Starting in December we will be conducting a trial on an organic dairy looking at some new anti-biofilm hyperactivating compounds as an alternative treatment for mastitis in dairy cattle on organic farms. Several farms have used these products in the past but there has not been a good study to evaluate their effectiveness relative to their costs. We hope to have some data and results available soon. Look for more information over the next few months.
Mastitis is an inflammation of the mammary gland typically caused by bacterial infection and is a significant animal health and economic issue for the dairy industry. It is estimated to cost the US dairy industry over $2 billion per year in reduced milk production, discarded milk, early cow culling, veterinary services, and treatment. In addition to the economic impacts, mastitis causes pain and suffering in affected cows leading to suboptimum animal welfare.
The AHV compounds show promise as an alternative mastitis treatment. These proprietary compositions developed by Agri-Dynamics are proposed to work by interfering with quorum sensing of bacteria to inhibit growth and biofilm formation. Initial studies indicate AHV Quick and AHV Extra can inhibit bacterial growth without inducing antibiotic resistance after repeated exposure. Research also shows AHV compounds can prevent biofilm formation at minimum inhibitory concentrations. Using AHV therapy to treat mastitis could benefit animal health and welfare while supporting sustainable agriculture practices to reduce antibiotic usage.
Animal Health Vision USA
7940 Lander Ave.
Suite 3
Hilmar, CA 95324
United States
Tel. +1 559-425-8112
Discover more from Texas A&M AgriLife Organic
Subscribe to get the latest posts sent to your email.
Texas A&M AgriLife Organic 